Figure S1 from kras and egfr Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in &Lt;i>egfr

openalex（2023）

Cited 0|Views2

No score

Key words

EGFR Mutations

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined

Figure S1 from &lt;i&gt;kras&lt;/i&gt; and &lt;i&gt;egfr&lt;/i&gt; Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in &Lt;i&gt;egfr&lt;/i&gt;